A pioneering life sciences company, ScubaTx, has successfully secured £1.5m to propel its innovative organ transplant technology. Having set its sights on Manchester Science Park, the firm is poised to leverage regional expertise.
The new funding round was spearheaded by GMC Life Sciences Fund, managed by Praetura, marking a significant leap in ScubaTx’s quest to enhance organ preservation techniques, thereby improving transplant success rates globally.
ScubaTx’s strategic decision to establish a base in Manchester is pivotal for advancing its organ preservation technology. Situated in Manchester Science Park, the firm aims to capitalise on the region’s robust life sciences sector. This move not only fosters collaboration with local experts but also accelerates its research and development initiatives.
The Manchester office is expected to enhance operational capabilities. By focusing on quality assurance, regulatory affairs, and engineering, ScubaTx plans to streamline its production processes. The strategic location enables the company to tap into Manchester’s extensive resources and professional networks, essential for its development journey.
Alongside this investment, ScubaTx benefits from existing investor contributions and additional grants from Innovate UK. This diverse funding portfolio permits the expansion of ScubaTx’s research efforts, crucial for refining its revolutionary ‘persufflation’ technique.
The method significantly extends the time that organs can be preserved, potentially transforming organ transplantation practices worldwide.
The leadership team is committed to expanding ScubaTx’s global presence, particularly in the United States, where interest in their techniques is growing.
This innovation not only promises to alleviate the burden on health systems but also offers hope to patients on long waiting lists worldwide.
These alliances are expected to fuel further innovation and open new avenues for organ preservation methods, making transformative impacts on the healthcare field.
Through rigorous research and collaboration, the team plays a pivotal role in ScubaTx’s goal to refine its organ preservation technologies.
With a robust funding framework and a strategic foothold in Manchester, ScubaTx is well-positioned to reshape the organ transplantation landscape. The firm’s commitment to innovative technology and global collaboration underscores its potential to make life-saving impacts on a global scale.
